Miltefosine

Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)

Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry

OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Miltefosine to Treat Mucocutaneous Leishmaniasis

Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

Short Course Regimens for Treatment of PKDL (Sudan)

Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨

Miltefosine for Children With PKDL

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Pharmacokinetics of Miltefosine in Children and Adults